ACUTE CHANGES IN CONCENTRATIONS OF APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-B, APOLIPOPROTEIN-C-II AND LIPOPROTEIN(A) IN SERUM COVERING THE PERIOD FROM DIRECTLY BEFORE TO 48 HOURS AFTER CHRONIC-HEMODIALYSIS
M. Schumacher et al., ACUTE CHANGES IN CONCENTRATIONS OF APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-B, APOLIPOPROTEIN-C-II AND LIPOPROTEIN(A) IN SERUM COVERING THE PERIOD FROM DIRECTLY BEFORE TO 48 HOURS AFTER CHRONIC-HEMODIALYSIS, European journal of clinical chemistry and clinical biochemistry, 32(3), 1994, pp. 123-125
This study reports the changes in total cholesterol, triacylglycerols,
apolipoproteins A-I, B, C-II and (a) before, directly after and 48 ho
urs after chronic renal dialysis on 46 non-selected patients (20 male,
26 female; time since first dialysis 1-203 months (median 22 months),
median age 52 years, range 25-82 years). Thirty six of the 46 patient
s (17 men and 19 women) suffered from hypertension. There were no sex-
linked differences in any analyte except cholesterol, which was signif
icantly higher in women than in men at all times. The apolipoproteins
were determined with immunoluminometric assays. Apolipoprotein C-II wa
s determined as the apolipoprotein C-II : apolipoprotein B complex. Li
poprotein(a) was determined using two antibodies directed against apol
ipoprotein(a). Significant increases (p < 0.05) in serum concentration
s before and after dialysis were seen for all analytes with the except
ion of cholesterol (no significant change) and apolipoprotein C-II (si
gnificant decrease). The median increases were: cholesterol 5%, triacy
lglycerols 28%, apolipoprotein A-I 19%, apolipoprotein B 11%, apolipop
rotein C-II -39%, lipoprotein(a) [all patients 21%, < 300 mg/l 8%, > 3
00 mg/l 163%]. The values 48 hours after dialysis were not significant
ly different from the value before dialysis for cholesterol (-5%), apo
lipoprotein B (0%) and lipoprotein(a) (-2% - all patients). Statistica
lly significant lower concentrations of apolipoprotein C-II (-28%) (p
< 0.01) and triacylglycerols (-19%) (p < 0.01) were observed, but not
investigated further. The behaviour of lipoprotein(a) was not correlat
ed with any of the other analytes except triacylglycerols, where a sta
tistically significant negative correlation was seen in all groups. Ap
olipoprotein B and apolipoprotein C-II, triacylglycerols and apolipopr
otein C-II, and apolipoprotein B and triacylglycerol concentrations we
re correlated at all three sampling times. Lipoprotein(a) correlated w
ith cholesterol only directly after dialysis, whereas cholesterol and
triacylglycerols correlated before and 48 hours after dialysis, but no
t directly after dialysis. None of the analytes correlated with the ti
me since the first dialysis, i. e. with the length of time on dialysis
. The results showed that dialysis by no means had a uniform effect on
the lipid analytes studied, and that those patients with elevated lip
oprotein(a) were subject to elevations of this analyte directly after
dialysis, which were on average more than three times those before dia
lysis. The clinical relevance of these findings must be investigated f
urther. The results indicate that it is important to standardise the b
lood sampling time for dialysis patients as results obtained before, d
uring, and immediately after dialysis may vary significantly.